Hulagno, John Kyle A.
HRN: 17-30-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/13/2022
06/20/2022
IV
1.5
Q8
Indirect Inguinal Hernia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes